Glutamate, opiates, neuropeptides, anandimide, and neuromodulators Flashcards
1
Q
Glutamate and aspartate
A
- Glu is major excitatory NT, both are implicated in excitotoxicity and have high-affinity reuptake systems
- Reuptake can be to glial cells, and uses Na/K gradients to facilitate reuptake
- Glutamate receptors: both gated ion channels (fast, ionotropic) and GPCR (slow, second messengers)
- All are excitatory: AMPA, Kainate, NMDA
- Selective agonists of metabotropic glu receptors (GPCRs) may be useful in Rx anxiety and schizophrenia
2
Q
AMPA and Kainate receptors
A
- AMPA: various forms of 16 different subunits, activation cause depolarization via outward flow of K and inward flow of Na (also permeable to Ca)
- AMPA found largely in striatum, hippocampus and cerebellum
- Influx of Ca can trigger apoptosis
- Kainate receptors: binds kainic acid better than glutamate, excessive excitation can lead to seizures and kill neurons
- Neuro-active steroids can protect against the seizures/toxicity
3
Q
NMDA receptors
A
- NMDA receptors: voltage sensitive (regulated by Mg) ad requires glycine as co-agonist along w/ Glu binding
- PCP (phencyclidine) compete w/ Mg for NMDA channel binding but are not removed w/ depolarization
- PCP produces delusions, hallucinations, and cognitive defects (high doses of etoh can produce similar effects)
- MSG also binds to these receptors
4
Q
Opiates
A
- Opiates are exogenous (morphine and codeine) and endogenous (endorphins, enkephalins, dynorphins) that bind to opioid receptors to produce analgesic effects
- Most potent compound is morphine and its antagonist is naloxone
- Morphine and endogenous opiates bind to the same receptors
- All endogenous opiates are made from a pro-peptide (POMC, pro-opiomelanocortin, makes beta-endorphin) by proteases to make pro-opioids (neuron specific)
5
Q
Opioid receptors
A
- 3 classes: mu, kappa, and delta
- Most significant is mu, since it binds most to morphine-like derivatives (naloxone, endorphins)
- Mu is a GPCR that activates cAMP in presynaptic cells to decrease NT release
- Also increases K efflux in postsynaptic cell to hyperpolarize neurons, which decreases the firing of pain neurons in the SC
- They inhibit pain pathways including presynaptic release of substance P (pain-causing neuro-peptide) which is released onto efferent neurons of STT tract to convey pain to the brain
- Capsaicin produces rapid release of substance P
- Other neuropeptides: nociceptin and nocistatin (regulate pain perception)
6
Q
Anandamide
A
- Derivative of arachidonic acid, actives cannabioid receptors (CB), same receptors THC activates
- CB1 found in CNS, CB2 has peripheral distribution (in leukocytes and testicles)
- CB1 acts via GPCR to reduce the presynaptic cell’s ability to conduct Ca and thus lowers NT release from presynaptic cell
- Most complicated effects of long term THC use are cognitive
7
Q
Neuromodulators
A
- In general are not release via synaptic vessels
- May not change the membrane potential of postsynaptic cell but changes the membrane’s capacity to respond to further signals
- Ex: protaglandins act on NE neurons to reduce NE release
- NO is also a neuromodulator that influences the levels of cGMP (released from postsynaptic cell to act on presynaptic cell like anandamide)